Advanced search
Start date
Betweenand


Evaluation of the expression of the tumor suppressor gene PTEN, proto-oncogene c-kit, matrilysin (MMP-7), Connexins 32 and 43 and E-caderinas/cateninas complex in mast cell tumors of dogs: ex vivo and in vitro studies

Full text
Author(s):
Ivone Izabel Mackowiak da Fonseca
Total Authors: 1
Document type: Doctoral Thesis
Press: São Paulo.
Institution: Universidade de São Paulo (USP). Faculdade de Medicina Veterinária e Zootecnia (FMVZ/SBD)
Defense date:
Examining board members:
Maria Lucia Zaidan Dagli; Heloisa Vasconcellos Amaral Caetano; Lucas Martins Chaible; Cristina de Oliveira Massoco Salles Gomes; Julia Maria Matera
Advisor: Maria Lucia Zaidan Dagli
Abstract

Mast cell tumors are malignant skin formations that most affect dogs, so many research projects are being directed at the discovery of new treatment options, diagnosis and prognosis of this disease. The objective of this study was to evaluate the expression of a set of proteins that are interlinked or interconnected signaling pathways, in an attempt to identify proteins that show differentially expressed in canine mast cell tumors of different grades. We performed a study of the expression of this set of 18 proteins in tumors originating from the files of the Service of Animal Pathology, Department of Pathology of the FMVZ - USP. We collected other 18 new samples of canine cutaneous mast cell tumors , which were subjected to cell culture , and 10 strains of canine cutaneous mast cell tumors were established in order to evaluate in vitro this same group of molecular markers. The samples were subjected to immunostainings the following proteins: PTEN, c-kit, E-cadherin, β-catenin, α-catenin, p120-catenin, MMP-7. In established tumor cell lines we analyzed the cell cycle, DNA ploidy, cell proliferation by CFSE, ultrastructural analysis by transmission electron microscopy , mutational analysis of c-kit gene, and analysis by immunocytochemistry and immunofluorescence of the following molecular markers: PTEN, c-kit, E-cadherin, β-catenin, α-catenin, p120-catenin, MMP-7, CX32, Cx43, vimentin, tryptase. The results demonstrate the altered expression of the proteins, c- Kit, MM7 and PTEN proteins according to the level of the canine mastocytoma E-caderina/catenina complex. It has been observed a reduced expression as well as alterations in subcellular localization of all these proteins in more aggressive tumors as in grade 3 mast cell tumors. The same was observed for Cx 43 and 32 proteins. It has been performed a survey of the medical records of 18 cases of canine mast cell tumors retrieved from the archives, and clinical parameters evaluated were age, race, gender, location, time of evolution, change lymph node metastasis, survival time, recurrence interval, death. Older animals, metastasis, and tumor location in the chest, and mast cell tumor grade: patients who had the following parameters were associated with a worse prognosis. In the established tumor cell lines, ploidy analysis revealed that all lines are diploid mastocytoma and CFSE proliferation showed that the maximum occurs within 24 hours of cultivation. The ultrastructural analysis showed that the tumor cells are mast cell lineages. Analysis by immunocytochemistry markers studied showed similar patterns to those found in immunohistochemistry. By expression of vimentin and tryptase confirmed once again the case of mast cell lines in culture. In mutational analysis of the c kit, mutations were found in exon 8 and 11, but not in exon 17. Our results show the simultaneous occurrence of numerous molecular alterations in canine mast cell tumors. Proteins have different functions and evaluated pathways, but that interlock may regulate or be regulated, depending on the moment of the cell. The destabilization of the complex E-cadherin-catenins seems to be the effector program in the progression of canine mast cell tumors. The main purpose of performing morphological, functional and molecular studies of tumors is to contribute, sooner or later, to the control of these diseases. Hopefully, with this work, we have provided important information which will facilitate the search for better treatment of canine mast cell tumors (AU)

FAPESP's process: 11/13260-5 - Evaluation of the expression of the tumor suppressor gene PTEN, of the proto-oncogene c-kit, matrilisin (MMP-7), connexins 32, 43 and of the e-cadherin/catenin complex in canine mast cell tumors
Grantee:Ivone Izabel Mackowiak da Fonseca
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)